002748.SZ
Jiangxi Selon Industrial Co., Ltd. [002748.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002748.SZ Stock Summary
Top 10 Correlated ETFs
002748.SZ
Top 10 Correlated Stocks
002748.SZ
In the News
002748.SZ Financial details
Company Rating
Strong Buy
Market Cap
2.08B
Income
55.46M
Revenue
2.16B
Book val./share
5.55
Cash/share
0.89
Dividend
-
Dividend %
-
Employees
1.48K
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
43.15
Forward P/E
-
PEG
-6.03
P/S
1.11
P/B
1.8
P/C
7.79
P/FCF
32.67
Quick Ratio
1.04
Current Ratio
1.3
Debt / Equity
0.27
LT Debt / Equity
0.11
-
-
EPS (TTM)
0.23
EPS next Y
-
EPS next Q
-
EPS this Y
-8.54%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
25.59%
Revenue last 5Y
11.78%
Revenue Q/Q
9.78%
EPS Q/Q
-156.22%
-
-
-
-
SMA20
-
SMA50
-11.11%
SMA100
-20%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.04%
Gross Margin
12%
Oper. Margin
3%
Profit Margin
3%
Payout
25%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.21-15.62
52W High
-53.8%
52W Low
+38.6%
RSI
38
Rel Volume
1.21
Avg Volume
9.05M
Volume
10.94M
Perf Week
-24.26%
Perf Month
-7.1%
Perf Quarter
-19.32%
Perf Half Y
-19.23%
-
-
-
-
Beta
0.235
-
-
Volatility
0.74%, 0.58%
Prev Close
-1%
Price
6.93
Change
3.9%
002748.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 6.26 | 7.71 | 6.55 | 9.06 | 10.8 | |
| Net income per share | 0.24 | -0.08 | -0.57 | 0.81 | 0.75 | |
| Operating cash flow per share | 0.03 | 0.07 | 0.26 | 1.73 | 0.39 | |
| Free cash flow per share | -0.56 | -1.19 | -0.55 | 1.48 | 0.04 | |
| Cash per share | 0.8 | 0.31 | 0.45 | 0.66 | 0.64 | |
| Book value per share | 4.92 | 4.67 | 4.04 | 4.85 | 5.59 | |
| Tangible book value per share | 4.67 | 4.47 | 3.86 | 4.7 | 5.43 | |
| Share holders equity per share | 4.92 | 4.67 | 4.04 | 4.85 | 5.59 | |
| Interest debt per share | 0.88 | 1.61 | 2.46 | 1.33 | 1.47 | |
| Market cap | 1.64B | 1.76B | 1.5B | 2.7B | 2.41B | |
| Enterprise value | 1.66B | 2.06B | 1.96B | 2.84B | 2.59B | |
| P/E ratio | 28.83 | -95.34 | -10.85 | 13.8 | 13.39 | |
| Price to sales ratio | 1.1 | 0.95 | 0.95 | 1.24 | 0.93 | |
| POCF ratio | 236.19 | 100.19 | 23.63 | 6.49 | 25.71 | |
| PFCF ratio | -12.45 | -6.15 | -11.3 | 7.61 | 267.99 | |
| P/B Ratio | 1.41 | 1.57 | 1.54 | 2.32 | 1.8 | |
| PTB ratio | 1.41 | 1.57 | 1.54 | 2.32 | 1.8 | |
| EV to sales | 1.11 | 1.11 | 1.24 | 1.3 | 1 | |
| Enterprise value over EBITDA | 12.15 | 23.33 | 13.31 | 7.32 | 7.26 | |
| EV to operating cash flow | 238.33 | 116.99 | 30.91 | 6.82 | 27.65 | |
| EV to free cash flow | -12.57 | -7.19 | -14.79 | 8 | 288.13 | |
| Earnings yield | 0.03 | -0.01 | -0.09 | 0.07 | 0.07 | |
| Free cash flow yield | -0.08 | -0.16 | -0.09 | 0.13 | 0 | |
| Debt to equity | 0.17 | 0.33 | 0.59 | 0.25 | 0.25 | |
| Debt to assets | 0.13 | 0.2 | 0.3 | 0.16 | 0.16 | |
| Net debt to EBITDA | 0.11 | 3.35 | 3.14 | 0.35 | 0.51 | |
| Current ratio | 1.97 | 1.06 | 0.7 | 1.17 | 1.32 | |
| Interest coverage | 16.31 | 0.59 | 2.49 | 10.6 | 13.81 | |
| Income quality | 0.12 | -0.95 | -0.46 | 2.07 | 0.52 | |
| Dividend Yield | 0.03 | 0.02 | 0.03 | 0.01 | 0.01 | |
| Payout ratio | 0.92 | -1.91 | -0.29 | 0.12 | 0.08 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0.01 | 0.01 | 0.03 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
| Capex to operating cash flow | -19.97 | -17.28 | -3.09 | -0.15 | -0.9 | |
| Capex to revenue | -0.09 | -0.16 | -0.12 | -0.03 | -0.03 | |
| Capex to depreciation | -2.03 | -3.89 | -2.12 | -0.51 | -0.7 | |
| Stock based compensation to revenue | 0 | 0 | 0.03 | 0 | 0 | |
| Graham number | 5.15 | 2.85 | 7.23 | 9.43 | 9.72 | |
| ROIC | 0.04 | 0.01 | 0.03 | 0.15 | 0.11 | |
| Return on tangible assets | 0.04 | -0.01 | -0.08 | 0.11 | 0.09 | |
| Graham Net | 0.71 | -0.95 | -2.38 | -1.39 | -0.87 | |
| Working capital | 317.25M | 33.63M | -171.33M | 70.66M | 182.52M | |
| Tangible asset value | 1.11B | 1.07B | 926.49M | 1.13B | 1.3B | |
| Net current asset value | 299.92M | -75.67M | -464.62M | -198.4M | 13.3M | |
| Invested capital | 0.17 | 0.33 | 0.59 | 0.25 | 0.25 | |
| Average receivables | 350.15M | 399.4M | 300.03M | 163.68M | 264.26M | |
| Average payables | 86.99M | 102.3M | 133.73M | 154.49M | 157.76M | |
| Average inventory | 62.57M | 82.17M | 96.27M | 138.06M | 174.99M | |
| Days sales outstanding | 95.34 | 81.1 | 43.92 | 23.2 | 54.97 | |
| Days payables outstanding | 20.97 | 28.46 | 35.38 | 36.91 | 24.33 | |
| Days of inventory on hand | 20.5 | 20.13 | 25.91 | 37.65 | 29.64 | |
| Receivables turnover | 3.83 | 4.5 | 8.31 | 15.73 | 6.64 | |
| Payables turnover | 17.41 | 12.82 | 10.32 | 9.89 | 15 | |
| Inventory turnover | 17.81 | 18.13 | 14.09 | 9.7 | 12.31 | |
| ROE | 0.05 | -0.02 | -0.14 | 0.17 | 0.13 | |
| Capex per share | -0.58 | -1.27 | -0.81 | -0.26 | -0.35 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.56 | 2.56 | 2.18 | 2.03 | 2.23 | |
| Net income per share | 0.08 | 0.22 | 0.05 | -0.09 | 0.05 | |
| Operating cash flow per share | 0.08 | 0.22 | 0.05 | 0.08 | 0.19 | |
| Free cash flow per share | 0 | 0.16 | 0 | 0.03 | 0.12 | |
| Cash per share | 0.74 | 0.64 | 0.71 | 0.76 | 0.89 | |
| Book value per share | 5.38 | 5.59 | 5.6 | 5.5 | 5.55 | |
| Tangible book value per share | 5.23 | 5.43 | 5.32 | 5.19 | 5.24 | |
| Share holders equity per share | 5.38 | 5.59 | 5.6 | 5.5 | 5.55 | |
| Interest debt per share | 1.39 | 1.41 | 1.37 | 1.47 | 1.49 | |
| Market cap | 2.63B | 2.41B | 2.64B | 2.19B | 2.14B | |
| Enterprise value | 2.78B | 2.59B | 2.8B | 2.36B | 2.28B | |
| P/E ratio | 35.3 | 11.54 | 54.43 | -26.83 | 46.54 | |
| Price to sales ratio | 4.29 | 3.93 | 5.04 | 4.51 | 4 | |
| POCF ratio | 141.18 | 46.15 | 217.71 | 112.72 | 48.12 | |
| PFCF ratio | 2.65K | 62.15 | -2.51K | 306.07 | 75.71 | |
| P/B Ratio | 2.04 | 1.8 | 1.97 | 1.66 | 1.61 | |
| PTB ratio | 2.04 | 1.8 | 1.97 | 1.66 | 1.61 | |
| EV to sales | 4.53 | 4.22 | 5.34 | 4.85 | 4.27 | |
| Enterprise value over EBITDA | 93.68 | 55.8 | -249.55 | -116.78 | 154.77 | |
| EV to operating cash flow | 149.27 | 49.62 | 230.46 | 121.26 | 51.3 | |
| EV to free cash flow | 2.8K | 66.82 | -2.66K | 329.26 | 80.71 | |
| Earnings yield | 0.01 | 0.02 | 0 | -0.01 | 0.01 | |
| Free cash flow yield | 0 | 0.02 | 0 | 0 | 0.01 | |
| Debt to equity | 0.25 | 0.25 | 0.24 | 0.26 | 0.27 | |
| Debt to assets | 0.17 | 0.16 | 0.16 | 0.17 | 0.18 | |
| Net debt to EBITDA | 5.07 | 3.9 | -13.81 | -8.23 | 9.6 | |
| Current ratio | 1.41 | 1.32 | 1.36 | 1.41 | 1.3 | |
| Interest coverage | 6.71 | 12.52 | 4.47 | -6.91 | 3.92 | |
| Income quality | 1 | 1 | 1 | -0.95 | 3.87 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.22 | 0.06 | 0.32 | -0.17 | 0.29 | |
| Sales general and administrative to revenue | 0.11 | -0.09 | 0.05 | -0.02 | 0.12 | |
| Research and developement to revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
| Capex to operating cash flow | -0.95 | -0.26 | -1.09 | -0.63 | -0.36 | |
| Capex to revenue | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 | |
| Capex to depreciation | -0.53 | -0.4 | -0.38 | -0.36 | 0.26 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.07 | 5.23 | 2.53 | 3.25 | 2.44 | |
| ROIC | 0.01 | 0.04 | 0.01 | -0.01 | 0.01 | |
| Return on tangible assets | 0.01 | 0.03 | 0.01 | -0.01 | 0.01 | |
| Graham Net | -0.73 | -0.87 | -0.85 | -0.74 | -0.63 | |
| Working capital | 169.1M | 182.52M | 190.08M | 197.24M | 161.47M | |
| Tangible asset value | 1.26B | 1.3B | 1.28B | 1.25B | 1.26B | |
| Net current asset value | -41.48M | 13.3M | 11.28M | -1.03M | 10.74M | |
| Invested capital | 0.25 | 0.25 | 0.24 | 0.26 | 0.27 | |
| Average receivables | 258.8M | 330.54M | 358.13M | 322.35M | 332.45M | |
| Average payables | 156.22M | 146.5M | 157.46M | 144.61M | 116.45M | |
| Average inventory | 146.67M | 151.13M | 175.68M | 166.97M | 140.97M | |
| Days sales outstanding | 39.68 | 57.17 | 55.95 | 58.92 | 58.29 | |
| Days payables outstanding | 25.4 | 26.35 | 32.4 | 22.74 | 22.29 | |
| Days of inventory on hand | 21.73 | 32.09 | 33.42 | 30.41 | 24.15 | |
| Receivables turnover | 2.27 | 1.57 | 1.61 | 1.53 | 1.54 | |
| Payables turnover | 3.54 | 3.42 | 2.78 | 3.96 | 4.04 | |
| Inventory turnover | 4.14 | 2.8 | 2.69 | 2.96 | 3.73 | |
| ROE | 0.01 | 0.04 | 0.01 | -0.02 | 0.01 | |
| Capex per share | -0.07 | -0.06 | -0.06 | -0.05 | -0.07 |
002748.SZ Frequently Asked Questions
What is Jiangxi Selon Industrial Co., Ltd. stock symbol ?
Jiangxi Selon Industrial Co., Ltd. is a CN stock and trading under the symbol 002748.SZ
What is Jiangxi Selon Industrial Co., Ltd. stock quote today ?
Jiangxi Selon Industrial Co., Ltd. stock price is $6.93 today.
Is Jiangxi Selon Industrial Co., Ltd. stock public?
Yes, Jiangxi Selon Industrial Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 9.05M
- Market Capitalization 2.08B
- Employee 1.48K
- CEO Mr. Guoqing Wang
- Headquarters Leping,CN
- IPO Date 2015-03-19
-
Website
https://www.chinaselon.com.cn 
Jiangxi Selon Industrial Co., Ltd. researches, develops, produces, markets, and sells fine chemicals in China. It offers AC foaming agents, thionyl chloride, chlor-alkali, and other chemical products, as well as industrial sodium hydroxide, liquid chlorine, synthetic hydrochloric acid, and aqueous ammonia. The company also exports its products to approximately 30 countries in Southeast Asia, Central Asia, Europe, Latin America, and Africa. Jiangxi Selon Industrial Co., Ltd. was founded in 2003 and is based in Leping, China.
